Emer Kelly
- Toxicology top 10%
-
- Protease and Inhibitor Mechanisms 2
-
- Peptidase Inhibition and Analysis 2
-
- Blood Coagulation and Thrombosis Mechanisms 2
-
- Cystic Fibrosis Research Advances 2
- Neonatal Respiratory Health Research 2
-
- Tuberous Sclerosis Complex Research 1
-
- Selenium in Biological Systems 1
-
- Respiratory viral infections research 1
- Co-authors
- Catherine M. GreeneNoel G. McElvaneyShane O’NeillGarret CullenTomás P. CarrollClifford C. TaggartSinéad WeldonTeck Boon Low
- Cited by
- ToxicologyCancer ResearchImmunology
- Journals
- Journal of Biological Chemistry (1 paper)The Journal of Experimental Medicine (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- IrelandUnited States
In The Last Decade
Emer Kelly
9 papers receiving 484 citations
Peers
Comparison fields: 5 of 94
- Toxicology 27
- Cancer Research 93
- Immunology 111
- Geriatrics and Gerontology 18
- Microbiology 25
Countries citing papers authored by Emer Kelly
This map shows the geographic impact of Emer Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emer Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emer Kelly more than expected).
Fields of papers citing papers by Emer Kelly
This network shows the impact of papers produced by Emer Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emer Kelly. The network helps show where Emer Kelly may publish in the future.
Co-authorship network
The 15 scholars most cited alongside Emer Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 11 | |
| 2 | 2010 | 58 | |
| 3 | 2010 | 1 | |
| 4 | 2009 | 59 | |
| 5 | 2008 | 75 | |
| 6 | 2008 | 25 | |
| 7 | 2006 | 58 | |
| 8 | 2006 | 12 | |
| 9 | 2005 | 196 |
About Emer Kelly
Emer Kelly is a scholar working on Toxicology, Cancer Research and Gastroenterology, having authored 9 papers that have together received 495 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cystic Fibrosis Research Advances (2 papers), Neonatal Respiratory Health Research (2 papers), Tuberous Sclerosis Complex Research (1 paper), Selenium in Biological Systems (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Toxicology (27 citations), Cancer Research (93 citations) and Immunology (111 citations). Emer Kelly has collaborated with scholars based in Ireland and United States. Frequent co-authors include Catherine M. Greene, Noel G. McElvaney, Shane O’Neill, Garret Cullen, Tomás P. Carroll, Clifford C. Taggart, Sinéad Weldon, Teck Boon Low, Sally‐Ann Cryan and Frank E. Murray. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.